Features - Interviews, Research

Filter

Current filters:

InterviewsResearch

Popular Filters

EASD 2014: AstraZeneca highlights range of choice in its diabetes portfolio

EASD 2014: AstraZeneca highlights range of choice in its diabetes portfolio

29-09-2014

Diabetes is a firm priority of UK-based pharma major AstraZeneca and is in no danger of being side-lined,…

AstraZenecaBydureonDiabetesForxigaInterviewsOnglyzaPharmaceuticalResearchUK

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

04-02-2014

A UK-based mobile human monitoring company is making waves in health care as it aims to revolutionize…

BiotechnologyInterviewsPharmaceuticalResearchUK

IN FOCUS: Viiv Healthcare’s Tivicay offers new HIV treatment option for patients

IN FOCUS: Viiv Healthcare’s Tivicay offers new HIV treatment option for patients

03-02-2014

Global HIV company Viiv Healthcare has launched its first new treatment option for people with HIV today.

Anti-viralsAtriplaInterviewsIsentressPharmaceuticalPrezistaRegulationResearchTivicayUKViiV Healthcare

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

16-12-2013

The UK’s brightest bioscience companies met in London for the One Nucleus Genesis 2013 conference on…

BiotechnologyFinancialInterviewsMerck SeronoResearchUK

BIA UK BioScience Forum: Accelerating vaccine development

BIA UK BioScience Forum: Accelerating vaccine development

15-10-2013

Recent advances in vaccine development in the UK were heard by interested delegates at the UK BioScience…

BiotechnologyEuropeInterviewsResearchVaccines

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

20-09-2013

Fresh from their trip to the European Respiratory Society annual congress in Barcelona, Verona Pharma’s…

EuropeInterviewsPharmaceuticalResearchRespiratory and Pulmonary

IN FOCUS: Boehringer Ingelheim presents its

IN FOCUS: Boehringer Ingelheim presents its "long and healthy" R&D pipeline

02-08-2013

German family-owned drug major Boehringer Ingelheim presented its major pipeline developments at an R&D…

afatinibBoehringer IngelheimDiabetesEuropeInterviewslinagliptinnintedanibOncologyPharmaceuticalResearchRespiratory and Pulmonaryvolasertib

Back to top